Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy
Article
[키워드] Analysis
antibodies
antibody
antiviral efficacy
association
bamlanivimab/etesevimab
casirivimab/imdevimab
clinical
conducted
Course
COVID-19
Delta
Dual therapy
Efficacy
France
genomic
glycoprotein
growth
high risk
highlight
joint
management
monoclonal
monoclonal antibodies
monoclonal antibody
Mutation
mutation selection.
neutralization
omicron
overlap
Paris
Patient
patients died
patients treated
Prevent
Protein
resistance mechanism
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 variant
SARS-CoV-2-positive patients
selected
selective
severe COVID-19
spike
Spread
the Spike
therapy
treat
Treatment
treatment initiation
variant
variants
viral genome
Viral load
viral mutation
was done
[DOI] 10.1128/spectrum.02152-22 PMC 바로가기
[DOI] 10.1128/spectrum.02152-22 PMC 바로가기